Our data not only show that antibodies against citrullinated FN are present in RA patients, but also demonstrate that the anti-FN antibodies represent a subgroup of anti-CCP2 antibodies and that they can already be detected very early in the disease. The gene discussed is AGBL2; the disease is rheumatoid arthritis.